908 Devices’ Chief Executive Officer Kevin Knopp, Ph.D., reflects on the company’s history of innovation and discusses how they are leveraging novel microfluidics techniques and miniaturized mass spectrometry to serve a growing user base that spans from biopharma to homeland security.
.svg)
